Logo
x

Search

Subscribe Now

Roche

Roche’s Reports the US FDA’s Approval of Itovebi as a Treatment for HR+ and HER2- breast cancer with a PIK3CA mutation

Roche’s Reports the US FDA’s Approval of Itovebi as a Treatment for HR+ and HER2- breast cancer with a PIK3CA mutation

  • October 11, 2024
Roche’s Ventana CLDN18 (43-14A) RxDx Assay Receives CE Mark Approval to Diagnose G/GEJ Cancer Patients with CLDN18 Protein Expression

Roche’s Ventana CLDN18 (43-14A) RxDx Assay Receives CE Mark Approval to Diagnose G/GEJ Cancer Patients with CLDN18 Protein Express...

  • October 10, 2024
Roche Reports Topline Data from P-III (REGENCY) Trial of Gazyva/Gazyvaro (Obinutuzumab) for Treating Lupus Nephritis

Roche Reports Topline Data from P-III (REGENCY) Trial of Gazyva/Gazyvaro (Obinutuzumab) for Treating Lupus Nephritis

  • September 26, 2024
Roche Reports Topline Data from P-III (CENTERSTONE) Study of Xofluza to Reduce the Transmission of Influenza Virus

Roche Reports Topline Data from P-III (CENTERSTONE) Study of Xofluza to Reduce the Transmission of Influenza Virus

  • September 19, 2024
Roche Reports the US FDA’s Approval of Ocrevus Zunovo for Treating Relapse and Progressive Multiple Sclerosis

Roche Reports the US FDA’s Approval of Ocrevus Zunovo for Treating Relapse and Progressive Multiple Sclerosis

  • September 16, 2024
Roche’s Tecentriq Hybreza Receives the US FDA’s Approval for Cancer Treatment

Roche’s Tecentriq Hybreza Receives the US FDA’s Approval for Cancer Treatment

  • September 13, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.